BR112012015753A2 - composição nutricional com alto teor de proteína e baixa caloria para o estímulo de síntese de proteína muscular - Google Patents

composição nutricional com alto teor de proteína e baixa caloria para o estímulo de síntese de proteína muscular

Info

Publication number
BR112012015753A2
BR112012015753A2 BR112012015753A BR112012015753A BR112012015753A2 BR 112012015753 A2 BR112012015753 A2 BR 112012015753A2 BR 112012015753 A BR112012015753 A BR 112012015753A BR 112012015753 A BR112012015753 A BR 112012015753A BR 112012015753 A2 BR112012015753 A2 BR 112012015753A2
Authority
BR
Brazil
Prior art keywords
low calorie
nutritional composition
mammal
protein
high protein
Prior art date
Application number
BR112012015753A
Other languages
English (en)
Other versions
BR112012015753B1 (pt
Inventor
George Verlaan
Marion Jourdan
Yvette Charlotte Luiking
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=67844720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112012015753(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of BR112012015753A2 publication Critical patent/BR112012015753A2/pt
Publication of BR112012015753B1 publication Critical patent/BR112012015753B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

composição nutricional com alto teor de proteína e baixa caloria para o estímula de síntese de proteína muscular. a presente invenção refere-se ao uso de uma composição nuricional com alto teor de proteína e baixa caloria para uso na prevenção ou no tartamento de uma doença ou um estado de sáude em um mamífero, que envolve deterioração muscular, bem como a compostos nutricionais da composição com alto teor de proteína e baixa caloria específicos para estimular a síntese de proteína muscular em um mamífero. em particular, a invenção refere-se ao uso de uma composição nurticional que compreende por 100 kcal: (i) pelo menos aproximadamente 12 g de matéria proteinácea que compreende pelo menos aproximadamente 80 % em peso de proteína do soro do leite, em relação á matéria proteinácea total e que compreende pelo menos aproximadamente 11% em peso de leucina, em relação à matéria proteinácea total, da qual menos aproximadamente 20% em peso estão em uma forma livre, em relação à leucina total, (ii) uma fonte de gordura e uma fonte de carboidratos que pdoem ser digeridos, para a prevenção ou para o tratamento de uma doença ou um estado de saúde que envolve deterioração muscular em um mamífero, especialmente em um mamífero idoso, em que a composição nutricional é administrada na forma de 1 até 2 porções ao dia, cada proção compreendendo entre 80 e 200 kcal.
BR112012015753-1A 2009-12-24 2010-12-23 Composição nutricional líquida e sólida com alto teor de proteína e baixa caloria BR112012015753B1 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NLPCT/NL2009/050806 2009-12-24
NL2009000508 2009-12-24
PCT/NL2009/050806 WO2011078654A1 (en) 2009-12-24 2009-12-24 Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis
PCT/NL2010/050887 WO2011078677A2 (en) 2009-12-24 2010-12-23 Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis

Publications (2)

Publication Number Publication Date
BR112012015753A2 true BR112012015753A2 (pt) 2016-05-17
BR112012015753B1 BR112012015753B1 (pt) 2019-11-26

Family

ID=67844720

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012015753-1A BR112012015753B1 (pt) 2009-12-24 2010-12-23 Composição nutricional líquida e sólida com alto teor de proteína e baixa caloria

Country Status (13)

Country Link
US (1) US8846759B2 (pt)
EP (2) EP2865382B1 (pt)
JP (1) JP5830030B2 (pt)
CN (1) CN102665736B (pt)
AU (1) AU2010335044B2 (pt)
BR (1) BR112012015753B1 (pt)
ES (2) ES2660312T3 (pt)
LT (1) LT2865382T (pt)
MX (1) MX344088B (pt)
PL (2) PL2865382T3 (pt)
RU (1) RU2551089C2 (pt)
TR (1) TR201802154T4 (pt)
WO (2) WO2011078654A1 (pt)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010002242A1 (en) * 2008-07-02 2010-01-07 N.V. Nutricia Nutritional composition for improving muscle function and daily activity
WO2011078654A1 (en) 2009-12-24 2011-06-30 N.V. Nutricia Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis
WO2012005568A1 (en) 2010-07-07 2012-01-12 N.V. Nutricia Nutritional composition for the stimulation of muscle protein synthesis
WO2012091542A1 (en) * 2010-12-28 2012-07-05 N.V. Nutricia Combination of components for the prevention and treatment of frailty
EP2580967A1 (en) 2011-10-11 2013-04-17 Nestec S.A. Accelerating muscle recovery after immobilization-induced muscle atrophy
EP2583565A1 (en) * 2011-10-21 2013-04-24 Nestec S.A. Use of whey protein micelles for enhancing energy expenditure and satiety
EP2583563A1 (en) * 2011-10-21 2013-04-24 Nestec S.A. Whey protein micelles against muscle atrophy and sarcopenia
EP2583566B1 (en) * 2011-10-21 2015-08-19 Nestec S.A. Whey protein micelles to enhance muscle mass and performance
US9598474B2 (en) * 2012-03-26 2017-03-21 Axcella Health, Inc. Nutritive fragments, proteins and methods
WO2013148329A1 (en) 2012-03-26 2013-10-03 Pronutria, Inc. Charged nutritive proteins and methods
JP2015518470A (ja) 2012-03-26 2015-07-02 プロニュートリア・インコーポレイテッドPronutria, Inc. 栄養タンパク質および方法
AU2013240271A1 (en) 2012-03-26 2014-10-02 Axcella Health Inc. Nutritive fragments, proteins and methods
GB201210100D0 (en) * 2012-06-08 2012-07-25 Whey Forward Health Ind Ltd Nutraceutical pharmaceutical composition
WO2014055905A1 (en) * 2012-10-04 2014-04-10 Abbott Laboratories Methods for enhancing the effect of egcg on mitigating skeletal muscle loss
WO2014134225A2 (en) * 2013-02-26 2014-09-04 Pronutria, Inc. Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance
US9597367B2 (en) * 2013-04-19 2017-03-21 Bioventures, Llc Methods for improving muscle and heart function
WO2014191856A1 (en) * 2013-05-31 2014-12-04 Nestec S.A. Methods for enhancement of muscle protein synthesis
LT3021690T (lt) * 2013-06-10 2017-07-10 N.V. Nutricia Raumenų išsaugojimas viršsvorį turintiems arba nutukusiems suaugusiams svorio metimo programos metu
US9596870B2 (en) * 2013-06-28 2017-03-21 Nestec Sa Compositions and methods for enhancing exercise performance
KR20160056941A (ko) * 2013-09-25 2016-05-20 프로뉴트리아 바이오사이언시스, 인코퍼레이티드 당뇨병 및 비만의 예방 및 치료를 위한 조성물 및 제형, 그리고 글루코스 및 열량 제어에서 이들의 생성방법 및 용도
CN103766696B (zh) * 2013-12-26 2015-08-26 北京康比特体育科技股份有限公司 一种具有增肌功能的组合物及其制备方法
EP3220754B1 (en) * 2014-11-19 2019-04-10 Nestec S.A. Use of complexes of whey protein micelles and pectin for managing body weight
WO2017069611A1 (en) 2015-10-23 2017-04-27 N.V. Nutricia Nutritional product for decreasing phenylalanine levels in pku patients
US10188135B2 (en) * 2015-11-04 2019-01-29 Stokley-Van Camp, Inc. Method for inducing satiety
JP6948103B2 (ja) * 2016-04-14 2021-10-13 株式会社明治 フレイル改善用組み合わせ物
BR112018074728B1 (pt) * 2016-06-10 2022-11-22 Société Des Produits Nestlé S.A Composição enteral líquida esterilizada por calor, seu uso e seu processo de preparação, e usos de uma fonte de proteína e de proteína do soro do leite
BR112018073930B1 (pt) 2016-06-10 2022-08-30 Société des Produits Nestlé S.A. Composições enterais com alto teor de proteína esterilizada por calor contendo proteína de soro de leite que compreende micelas de proteína de soro de leite e uma fonte de caseína, seu processo de preparação, e usos de uma fonte de proteína e de micelas de proteína de soro de leite em combinação com uma fonte de caseína
JP7218987B2 (ja) * 2016-08-08 2023-02-07 株式会社明治 酸性液状栄養組成物
EP3711493A1 (en) * 2016-11-16 2020-09-23 Fresenius Kabi Deutschland GmbH Nutritional composition for use in therapy of patients with sarcopenia and/or frailty or pre-sarcopenic and/or pre-frail patients
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CU20200012A7 (es) 2017-08-14 2021-02-04 Axcella Health Inc Composiciones de aminoácidos para el tratamiento de enfermedad hepática
CH714189A1 (de) * 2017-09-25 2019-03-29 Omanda Ag Verfahren zur Herstellung von L-Leucin und Molkenprotein L-Leucin zur Nahrungsanreicherung und dessen Anwendung.
US11273138B2 (en) 2017-11-02 2022-03-15 Bioventures, Llc Use of amino acid supplementation for improved muscle protein synthesis
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
AU2018390799A1 (en) * 2017-12-20 2020-05-07 Societe Des Produits Nestle S.A. Compositions and methods using high protein for induction of autophagy
EP3727419A1 (en) * 2017-12-20 2020-10-28 Société des Produits Nestlé S.A. Compositions and methods using a combination of autophagy inducer and high protein for induction of autophagy
BR112020019737A2 (pt) * 2018-03-27 2021-02-17 N.V. Nutricia uso de uma composição
BR112020021283A2 (pt) * 2018-04-18 2021-01-26 Worlds Greatest Ingredients, LP composição para aumentar massa muscular, e, métodos para prevenir ou tratar atrofia muscular e para aumentar massa muscular e/ou força muscular.
CN110558569B (zh) * 2018-06-05 2024-03-12 费森尤斯卡比德国有限公司 包含酸性乳清衍生蛋白质的透明液体营养组合物
JP2021527670A (ja) 2018-06-20 2021-10-14 アクセラ・ヘルス・インコーポレイテッドAxcella Health Inc. 筋肉中の脂肪浸潤の治療のための組成物及び方法
US11058139B2 (en) * 2018-07-03 2021-07-13 Kerri Ann Langhorne Recovery supplement for horses
CN109077302A (zh) * 2018-07-18 2018-12-25 辰欣药业股份有限公司 一种治疗和预防老年肌肉衰减综合症的医用食品及其制备方法
JP7044306B2 (ja) * 2018-07-31 2022-03-30 ユーハ味覚糖株式会社 ロイシン血中濃度上昇促進剤及びその用途
CN109198520A (zh) * 2018-10-13 2019-01-15 赤峰禾士营养食品科技有限公司 一种具有增肌功能的复合型营养健肌粉及其制备方法
CN111248289B (zh) * 2018-11-30 2023-04-07 内蒙古伊利实业集团股份有限公司 一种组合物、其制备方法及用途
WO2020118196A1 (en) * 2018-12-06 2020-06-11 Nutrient Foods, Llc Edible high nutrient density composite and the use for reduction and management of human hypertension
JP2020150805A (ja) * 2019-03-18 2020-09-24 株式会社0 タンパク質高含有アイスクリーム
CH715997A1 (de) * 2019-03-25 2020-09-30 Omanda Ag Proteingetränk und Darreichungseinheit zur Verabreichung von mit L-Leucin-angereicherten Molkenproteinkomponenten als Nahrungsanreicherung und dessen Herstellung.
CN113840536A (zh) * 2019-05-31 2021-12-24 雀巢产品有限公司 用于在动物中提供健康有益效果的基于mct的营养共混物
CA3138033A1 (en) * 2019-06-07 2020-12-10 Whitewave Services Inc. Plant-based protein mixtures and nutritional compositions
CA3141621A1 (en) * 2019-06-20 2020-12-24 Societe Des Produits Nestle S.A. Compositions and methods using thymol and/or carvacrol for induction of autophagy
WO2022035245A1 (ko) * 2020-08-14 2022-02-17 서울대학교병원 초저열량 및 고생체흡수율 단백질 식품 조성물 및 이를 이용한 식이 요법 정보 제공 방법
CN115474688A (zh) * 2021-06-16 2022-12-16 法尔玛国际健康管理有限公司 一种提升免疫力和增加肌肉的营养组合物
CN113412936A (zh) * 2021-07-14 2021-09-21 复旦大学附属中山医院 一种肌少症患者的肠内营养制剂
CN115886076B (zh) * 2022-11-26 2024-04-19 黑龙江飞鹤乳业有限公司 含亮氨酸类蛋白反应产物的组合物及在抗肌肉衰减的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888552A (en) 1988-04-29 1999-03-30 Immunotec Research Corporation Ltd. Anti-cancer therapeutic compositions containing whey protein concentrate
EP1037537B1 (en) 1997-12-11 2002-04-10 Arla Foods amba A process for preparing a kappa-caseino glycomacropeptide or a derivative thereof
DE10006989A1 (de) 2000-02-16 2001-08-23 Nutricia Nv Antiadhäsive Kohlenhydratmischung
RU2335927C2 (ru) * 2002-09-20 2008-10-20 Новартис Аг Обогащенные лейцином питательные композиции
US7288570B2 (en) * 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins
CN101987107A (zh) 2003-10-24 2011-03-23 努特里奇亚有限公司 免疫调节性寡糖
EP1865944B1 (en) 2005-03-29 2018-08-29 Ajinomoto Co., Inc. Amino acid-containing composition used for preventing or remedying decrease in skeletal muscle mass of aged people, comprising L-leucine
ATE487390T1 (de) 2005-08-23 2010-11-15 Herberger Dr Armand Proteinzusammensetzung zur behandlung eines physiologisch bedingten, klinisch unauffälligen proteinmehrbedarfs
EP1774973A1 (en) * 2005-10-12 2007-04-18 Nutricia N.V. Leucine rich composition
DK1983849T3 (da) 2006-01-20 2013-07-08 Innova Food Ab Fødevaresammensætning omfattende aminosyrer
US20070248648A1 (en) 2006-04-20 2007-10-25 Next Proteins, Inc. High protein, fatigue reducing powder
US20070280997A1 (en) * 2006-05-31 2007-12-06 Pacifichealth Laboratories, Inc. Composition for enhancing muscle recovery
US20090042770A1 (en) 2007-01-14 2009-02-12 Bastian Eric D Branched Chain Amino Acid Chelate
WO2008086538A1 (en) 2007-01-14 2008-07-17 Glanbia Plc Branched chain amino acid chelate
WO2009113845A1 (en) 2008-03-12 2009-09-17 N.V. Nutricia High protein liquid enteral nutritional composition
WO2011078654A1 (en) 2009-12-24 2011-06-30 N.V. Nutricia Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis

Also Published As

Publication number Publication date
ES2660312T3 (es) 2018-03-21
MX2012007232A (es) 2012-07-30
LT2865382T (lt) 2018-04-10
WO2011078654A1 (en) 2011-06-30
CN102665736A (zh) 2012-09-12
PL2515920T3 (pl) 2015-04-30
WO2011078677A2 (en) 2011-06-30
EP2515920B1 (en) 2014-12-17
AU2010335044A1 (en) 2012-07-26
EP2515920A2 (en) 2012-10-31
BR112012015753B1 (pt) 2019-11-26
AU2010335044B2 (en) 2015-11-19
TR201802154T4 (tr) 2018-03-21
RU2012131518A (ru) 2014-01-27
RU2551089C2 (ru) 2015-05-20
US20130203658A1 (en) 2013-08-08
JP2013515718A (ja) 2013-05-09
MX344088B (es) 2016-12-05
US8846759B2 (en) 2014-09-30
ES2528405T3 (es) 2015-02-10
JP5830030B2 (ja) 2015-12-09
EP2865382B1 (en) 2018-01-17
PL2865382T3 (pl) 2018-06-29
EP2865382A1 (en) 2015-04-29
WO2011078677A3 (en) 2011-09-09
CN102665736B (zh) 2014-10-29

Similar Documents

Publication Publication Date Title
BR112012015753A2 (pt) composição nutricional com alto teor de proteína e baixa caloria para o estímulo de síntese de proteína muscular
Phillips Nutrient-rich meat proteins in offsetting age-related muscle loss
Willems et al. Diet and exercise: a match made in bone
PH12020500169A1 (en) Compositions and methods for improving mitochondrial function and treating neurodenegenerative diseases and cognitive disorders
BR112012033422B8 (pt) formulação de alimentação por sonda de alimentação diária completa, seu uso e seu método de fabricação
BRPI0718596B8 (pt) composições farmacêuticas para terapia de combinação com inibidores de sglt-2 e metformina
BR112013000446A2 (pt) composição nutricional para a estimulação de síntese de proteína muscular
MY151018A (en) Use of nutritional compositions for preventing disorders
RU2013135312A (ru) Немедицинское увеличение или поддержание массы тела млекопитающего
Rizzoli Nutrition and sarcopenia
Guimarães-Ferreira et al. Synergistic effects of resistance training and protein intake: practical aspects
BR112020006471A2 (pt) composições e métodos que usam oleuropeína ou curcumina para massa muscular e/ou qualidade muscular
BR112015030767A2 (pt) uso de uma composição; e método para a conservação da massa muscular ou estimulação do aumento da massa muscular ou redução do risco de sarcopenia em adultos obesos ou com sobrepeso de pelo menos 40 anos de idade que participam de um programa de perda de peso
Mutnuri et al. Suppression of parathyroid hormone in a patient with severe magnesium depletion
Rodriguez et al. Effective translation of current dietary guidance: understanding and communicating the concepts of minimal and optimal levels of dietary protein
JP2015533509A5 (pt)
PH12021550331A1 (en) Acylated calcitonin mimetics
ECSP13012798A (es) Método para inhibir patógenos usando una composición nutricional
Paddon‐Jones et al. Variation in protein origin and utilization: research and clinical application
BRPI0508181A (pt) componentes de laticìnio eficazes para a perda de gordura
IN2014MN00932A (pt)
Tahami et al. Effect of organic acids supplementation on some gastrointestinal tract characteristics and small intestine morphology of broiler chickens.
Ono et al. Effect of an intermittent eight-hour joint fixation period on joint contractures in rats
BR112016012233A8 (pt) composições compreendendo cinamaldeído, e seus usos
BR112019005785A2 (pt) métodos que reduzem os desejos alimentares, pro-movem perda de peso e/ou tratam sobrepeso ou obesidade

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 7.4 NA RPI NO 2449 DE 12/12/2017 POR TER SIDO INDEVIDA.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/12/2010, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/12/2010, OBSERVADAS AS CONDICOES LEGAIS